Emergent Biosolutions IncAdd to My Watchlist

EBS:USNew YorkIndustry: Medical-Biomedical/Gene
  • 29.49
  • 0.67  -2.22%
    Today's Change
  • 30.16
    Previous Close
  • Today
    52 Week Low - High
8:04 pm ET 4/17/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding38 million
Market Cap$1 billion
Return on Equity ttm7.05%
Last DividendEBS:US does not pay a dividend
EPS: Year Actual ttm0.928
EPS: Year Est. 12/15 ttm0.680
EPS: Quarterly Actual 12/14 0.70
EPS: Quarterly Est. 3/15 -0.52
Price/Earnings ttm31.76
Relative Price/Earnings1.729
Earnings Growth Rate13.95
Company Description
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
Revenue$450 million
Net Income$37 million
Total Assets$945 million
Web Sitewww.emergentbiosolutions.com

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!